NDC 70771-1109-2 - ezetimibe
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70771-1109
- Requested NDC
- 70771-1109-2
- Package NDCs from labels
- 70771-1109-3, 70771-1109-9, 70771-1109-1, 70771-1109-5, 70771-1109-0, 70771-1109-2, 70771-1109-4
- Manufacturer
- Zydus Lifesciences Limited
- Effective date
- 2024-11-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ezetimibe - Zydus Lifesciences Limited | Zydus Lifesciences Limited | 2024-11-28 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70771-1109-0 | ezetimibe | 1000 in 1 BOTTLE | TABLET | 1000 | 5 | |
| 70771-1109-1 | ezetimibe | 100 in 1 BOTTLE | TABLET | 100 | 5 | |
| 70771-1109-2 | ezetimibe | 10 in 1 BLISTER PACK | TABLET | 10 | 5 | |
| 70771-1109-3 | ezetimibe | 30 in 1 BOTTLE | TABLET | 30 | 5 | |
| 70771-1109-4 | ezetimibe | 10 in 1 CARTON | TABLET | 10 | 5 | |
| 70771-1109-5 | ezetimibe | 500 in 1 BOTTLE | TABLET | 500 | 5 | |
| 70771-1109-9 | ezetimibe | 90 in 1 BOTTLE | TABLET | 90 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70771-1109 | EZETIMIBE TABLET [ZYDUS LIFESCIENCES LIMITED] | 5 | Current NDC, Legacy NDC, 7 package rows | 20241201_de814dcd-4759-4e9c-a650-335fb885a79d.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ezetimibe | EZETIMIBE | Marlex Pharmaceuticals, Inc. | 109a22f4-a7cb-96c6-e063-6394a90ad7f6 | 2026-11-04 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Clear Eyes Triple Relief | POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE | Prestige Brands Holdings, Inc. | 1269a1a6-843d-4d08-bb3c-c1f3d2e7080d | 2026-10-23 | Warnings | FZ989GH94E |
| Ezetimibe | EZETIMIBE | A-S Medication Solutions | c37c695b-fb40-423c-9b73-d1aa58a34db9 | 2026-10-08 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| REFRESH Classic | POLYVINYL ALCOHOL, POVIDONE | Allergan, Inc. | 31bf1d6c-9719-4060-b6a3-409a2fe7b560 | 2026-09-15 | Warnings | FZ989GH94E |
| ezetimibe | EZETIMIBE | Safecor Health, LLC | 6407d7f3-fd92-4c36-b561-f95ab7ebe055 | 2026-09-10 | Warnings, Adverse reactions | ANDA204331 349556 EOR26LQQ24 |
| Leader Artificial Tears 15 mL | POLYVINYL ALCOHOL, POVIDONE | Cardinal Health | 8cccc589-3a8e-baad-e053-2a95a90ab8c7 | 2026-09-09 | Warnings | FZ989GH94E |
| FRESHKOTE PRESERVATIVE FREE LUBRICANT EYE DROPS | POVIDONE, POLYVINYL ALCOHOL SOLUTION | Harrow Eye, LLC | 049e9cc9-0663-53bc-e063-6294a90a2c4f | 2026-09-04 | Warnings | FZ989GH94E |
| ezetimibe and simvastatin | EZETIMIBE AND SIMVASTATIN | NORTHSTAR RX LLC | 52a46269-2262-4052-a3ff-5455523f591f | 2026-09-01 | Warnings, Adverse reactions | EOR26LQQ24 |
| Rohto Optic Glow | NAPHAZOLINE HYDROCHLORIDE, POVIDONE, PROPYLENE GLYCOL | The Mentholatum Company | df9c5f7c-96e6-4b2b-b8cb-21a6a3342dff | 2026-08-20 | Warnings | FZ989GH94E |
| Rohto Preservative Free Dry Aid | POVIDONE, PROPYLENE GLYCOL | The Mentholatum Company | f4b1974c-2412-45f6-b79d-88b8a0bcb608 | 2026-08-18 | Warnings | FZ989GH94E |
| Rohto Dry-Aid | POVIDONE, PROPYLENE GLYCOL | The Mentholatum Company | 8ea5c6c9-48f4-406a-a2cb-9280c546d87d | 2026-08-18 | Warnings | FZ989GH94E |
| Caring Mill Lubricant Eye Drops | GLYCERIN, POVIDONE | FSA Store Inc | 2f735cdf-6530-1adf-e063-6394a90ab16a | 2026-08-16 | Warnings | FZ989GH94E |
| GOOD NEIGHBOR PHARMACY ARTIFICAL TEARS LUBRICANT EYE DROPS | POLYVINYL ALCOHOL, POVIDONE | AmerisourceBergen | ce6852a8-c5e6-403d-a7b4-a2e85d1ebb1f | 2026-07-22 | Warnings | FZ989GH94E |
| Ezetimibe | EZETIMIBE | A-S Medication Solutions | 090776cf-f211-49a3-a993-ff5d707311f2 | 2026-07-06 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Ezetimibe | EZETIMIBE | A-S Medication Solutions | a1cc2018-72a3-48bc-90de-c460f224cf5a | 2026-07-06 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
| Nexlizet | BEMPEDOIC ACID AND EZETIMIBE | Esperion Therapeutics, Inc. | 3fa2108c-0300-47b8-9d34-f762af7c93c6 | 2026-06-25 | Warnings, Adverse reactions | EOR26LQQ24 |
| Rohto Sun and Sport | HYPROMELLOSE, POVIDONE | The Mentholatum Company | 8bcc8882-b886-4b55-9bc4-d4b92a41358f | 2026-06-19 | Warnings | FZ989GH94E |
| Rohto Dual Light Relief | HYPROMELLOSE, POVIDONE | The Mentholatum Company | 1b597f83-d7f1-cf93-e063-6394a90a99f7 | 2026-06-19 | Warnings | FZ989GH94E |
| Ripple | GLYCERIN, POVIDONE | CorneaCare Inc | 3b5ba197-d501-681e-e063-6294a90aefb5 | 2026-05-24 | Warnings | FZ989GH94E |
| Ezetimibe | EZETIMIBE | Major Pharmaceuticals | e257ed7f-5015-4f1d-93f4-5adf5797643d | 2026-05-21 | Warnings, Adverse reactions | 349556 EOR26LQQ24 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.